DCGI grants EUA to Omicron-specific mRNA-based booster vaccine
New Delhi: The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology ...
New Delhi: The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology ...
Pune: Gennova Biopharmaceuticals Ltd., a subsidiary of Emcure Pharmaceuticals Ltd., announced that its mRNA vaccine – GEMCOVAC™-19 - against COVID ...